(ACRS) Aclaris Therapeutics - Performance 25.2% in 12m
ACRS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-23.35%
#86 in Peer-Group
Rel. Strength
71.82%
#2164 in Stock-Universe
Total Return 12m
25.20%
#38 in Peer-Group
Total Return 5y
-20.10%
#89 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 4.59 USD |
| 52 Week Low | 1.08 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 83.09 |
| Buy/Sell Signal +-5 | 0.66 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ACRS (25.2%) vs XLV (-5.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.36% | 135% | 355% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.34% | 16.6% | 86.1% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-2.05% | -15.3% | 417% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.68% | 4.53% | 55.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-4.16% | 7.17% | 55.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-2.74% | -5.77% | 51.3% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-8.26% | -8.51% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.73% | 19.8% | 64.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: ACRS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ACRS
| Total Return (including Dividends) | ACRS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.30% | 0.95% | 4.08% |
| 3 Months | 47.22% | 1.54% | 19.65% |
| 12 Months | 25.20% | -5.25% | 12.88% |
| 5 Years | -20.10% | 45.67% | 113.48% |
| Trend Score (consistency of price movement) | ACRS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 2.2% | 24.8% | 86.9% |
| 3 Months | 80.1% | -21.1% | 97.2% |
| 12 Months | 21.1% | -78.2% | 46% |
| 5 Years | -63.6% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th65.00 | 4.31% | 1.17% |
| 3 Month | %th73.50 | 44.99% | 23.04% |
| 12 Month | %th81.00 | 32.13% | 10.91% |
| 5 Years | %th54.00 | -45.15% | -62.57% |
FAQs
Does Aclaris Therapeutics (ACRS) outperform the market?
Yes,
over the last 12 months ACRS made 25.20%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.25%.
Over the last 3 months ACRS made 47.22%, while XLV made 1.54%.
Performance Comparison ACRS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ACRS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 10.3% | 1.2% | -44.1% | 12% |
| US NASDAQ 100 | QQQ | 10.6% | 1.2% | -45.4% | 14% |
| German DAX 40 | DAX | 8.2% | 3.4% | -56.1% | -7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.9% | 0% | -48.4% | 4% |
| Hongkong Hang Seng | HSI | 11.6% | 2.8% | -64.3% | -12% |
| India NIFTY 50 | INDA | 11.4% | 5.3% | -43.6% | 27% |
| Brasil Bovespa | EWZ | 15.8% | 3.4% | -60.1% | 23% |
ACRS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 11.7% | 3.2% | -47.6% | 2% |
| Consumer Discretionary | XLY | 10.4% | 2.8% | -36.4% | 9% |
| Consumer Staples | XLP | 11.7% | 5.4% | -43.2% | 18% |
| Energy | XLE | 8.5% | 0.1% | -37.6% | 23% |
| Financial | XLF | 11.3% | 1.7% | -47.8% | -2% |
| Health Care | XLV | 9.8% | 4.4% | -34.1% | 30% |
| Industrial | XLI | 9.5% | 0.4% | -51.1% | -0% |
| Materials | XLB | 9.4% | 1% | -47.5% | 19% |
| Real Estate | XLRE | 10.9% | 5.9% | -43.5% | 14% |
| Technology | XLK | 10.4% | -1.6% | -48.3% | 16% |
| Utilities | XLU | 9.5% | 2.5% | -46.4% | 3% |
| Aerospace & Defense | XAR | 10% | -1.2% | -62.2% | -23% |
| Biotech | XBI | 6.7% | 1.7% | -34.5% | 33% |
| Homebuilder | XHB | 7.1% | -3% | -39.7% | 19% |
| Retail | XRT | 10% | 2.5% | -38.6% | 14% |
ACRS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.2% | 0.01% | -29.1% | 32% |
| Natural Gas | UNG | 13.7% | 13.5% | -15.7% | 30% |
| Gold | GLD | 10.7% | 5.5% | -59% | -14% |
| Silver | SLV | 9.7% | 3.7% | -57.9% | 5% |
| Copper | CPER | 1.4% | -8.1% | -65.1% | 3% |
ACRS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 10.4% | 3.6% | -39.6% | 27% |
| iShares High Yield Corp. Bond | HYG | 10.7% | 4.1% | -40.6% | 16% |